References
- Nord C E. Studies on the ecological impacts of antibiotics. Eur J Clin Microbiol Infect Dis 1990; 9: 517–518
- Jacobs M R, Aronoff S C, Johenning S, Shlaes D M, Yamabe S. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli. Antimicrob Agents Chemother 1986; 29: 980–985
- Fortner C L, Finley R S, Schimpff S C. Piperacillin sodium: antibacterial spectrum, pharmacokinetics, clinical efficacy, and adverse reactions. Pharmacotherapy 1982; 2: 287–299
- Gutmann L, Kitzis M-O, Yamabe S, Acar J F. Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases. Antimicrob Agents Chemother 1986; 29: 955–957
- Heimdahl A, Nord C E. Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scand J Infect Dis 1979; 11: 233–242
- Nord C E, Heimdahl A, Kager L. Antimicrobial induced alterations in the human oropharyngeal and intestinal microflora. Scand J Infect Dis 1986, Suppl 49: 64–72
- Russo J, Thompson M, Russo M E, Saxon B A, Matsen J M, Moody F G, Rikkers L F. Piperacillin distribution into bile, gall-bladder wall, abdominal skeletal muscle and adipose tissue in surgical patients. Antimicrob Agents Chemother 1982; 22: 488–492
- Kager L, Malmborg A S, Nord C E, Sjöstedt S. The effect of piperacillin prophylaxis on the colonic microflora in patients undergoing colorectal surgery. Infection 1983; 11: 251–254